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Summary
Successful control of viral infection requires the host
to eliminate the infecting pathogen without causing
overt immunopathology. Herewe showed that perforin
(Prf1) and granzymes (Gzms) have distinct roles in
defensive immunity and immunopathology in a well-
established model of viral infection. Both Prf1 and
Gzms drastically affected the outcome of murine cyto-
megalovirus (MCMV) infection. Viral titres increased
markedly in both Prf12/2 and Gzma2/2Gzmb2/2 mice,
butGzma2/2Gzmb2/2mice recovered and survived in-
fection, whereas Prf12/2mice did not. Indeed, infected
Prf1-deficient hosts developed a fatal hemophago-
cytic lymphohistiocytosis (HLH)-like syndrome. This
distinction in outcome depended on accumulation of
mononuclear cells and T cells in infected Prf12/2
mice. Importantly, blocking experiments that clearly
identified tumor necrosis factor-a (TNF-a) as the prin-
cipal contributor to the lethality observed in infected
Prf12/2mice provided support for the clinical potential
of such an approach in HLH patients whose disease is
triggered by viral infection.
Introduction
Recovery from viral infections requires the generation of
effective antiviral responses that can eliminate, or at
least control, the infecting pathogen. This should occur
without causing overt immunopathology, because the
latter would augment disease. Pathology during viral in-
fection is often not due to damage caused directly by the
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5 These authors contributed equally to this work.virus. Rather, in many circumstances, antiviral immune
responses are responsible for the pathology that ac-
companies the infection (Chisari and Ferrari, 1995; Zin-
kernagel et al., 1999; Maini et al., 2000). In trying to treat
common infections, it is important to understand the
mechanisms that regulate pathogen elimination, immu-
nity, and pathology, so that immune-mediated damage
is prevented. Infection of mice by murine cytomegalovi-
rus (MCMV) represents an ideal experimental model be-
cause of the similarity in structure and biology between
human and murine CMV and because it permits the
study of in vivo infection in the natural host. MCMV infec-
tion is characterized by acute infection, followed by
a chronic, persistent phase and, ultimately, lifelong in-
fection of the host. The immune responses controlling
infection during these sequential stages are complex,
involving an orchestrated sequence of events induced
both by immune cells and by cytokines.
Natural killer (NK) cells restrict MCMV infection in
C57BL/6 (B6) mice through perforin-mediated cytotox-
icity and the release of antiviral cytokines like inter-
feron-g (IFN-g) (Biron et al., 1999). In addition, NK cells
can indirectly modulate antiviral immunity by producing
cytokines that activate bystander effectors and/or by
eliminating antigen-presenting cells like dendritic cells
(DCs) (Marcenaro et al., 2005). Thus, NK cells can po-
tentially regulate adaptive immune responses (Degli-
Esposti and Smyth, 2005; Marcenaro et al., 2005). Antivi-
ral activities mediated by both CD8+ and CD4+ T cells are
essential to clear the virus and to control persistent in-
fection (Koszinowski et al., 1991). CD8+ T cells mediate
antiviral activities through cytotoxic mechanisms or
through the release of IFN-g. IFN-g can interfere with
virus replication directly or through enhancement of T
helper 1 (Th1) responses.
NK cells and CD8+ cytotoxic T cells (CTLs) mediate
cytotoxicity mainly by granule exocytosis (Kagi et al.,
1994b; Trapani and Smyth, 2002). The granule exocyto-
sis pathway relies primarily on a family of structurally
related serine proteases, the granzymes (Gzms), and
the membrane-disrupting protein perforin (Prf1). The
exact mechanism of Prf1 action and the role of Gzms
in biological responses have been debated extensively
(Trapani and Smyth, 2002; Raja et al., 2003; Russell
and Ley, 2002). The role of Gzma and Gzmb in inducing
cell death is well established; however, other Gzms (e.g.,
c and m) and nongranzyme granule proteins may also
be involved in Prf1-mediated cytotoxicity (Mac Donald
et al., 1999; Johnson et al., 2003; Kelly et al., 2004).
Mice lacking Prf1 display severe immunodeficiency and
do not efficiently control a number of viral and tumor
challenges (Kagi et al., 1994a; Lowin et al., 1994; Smyth
et al., 2000). The best-characterized members of the
Gzm family are Gzma and Gzmb (Trapani et al., 2000;
Smyth et al., 2001; Lieberman, 2003). Gzmb induces ap-
optosis by activating caspase-dependent and -indepen-
dent pathways (Trapani and Sutton, 2003). Gzma acts in
a caspase-independent manner to induce a cell death
exhibiting all the features of apoptosis, except that the re-
sultant DNA damage seems to be due to single-stranded
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granule exocytosis process to utilize distinct molecular
pathways to induce cell death may make this form of
apoptosis most effective at controlling viruses.
The role of cytotoxic granule molecules in immunoreg-
ulation and immunopathology is not fully understood.
Prf1 plays a role in immunoregulation (de Saint Basile
and Fischer, 2001; Trapani and Smyth, 2002), and
Prf12/2mice infected with lymphocytic choriomeningitis
virus (LCMV) develop a haemophagocytic lymphohistio-
cytosis (HLH)-like syndrome. In these mice, infection is
lethal because of immune damage caused by uncon-
trolled regulation of CTLs and macrophages and overt
production of IFN-g (Matloubian et al., 1999; Jordan
et al., 2004). Indeed, it is believed that in several settings
of infection, immunopathology can be restricted by Prf1-
dependent negative regulation of CTL responses (Kagi
et al., 1999; Matloubian et al., 1999; Badovinac et al.,
2003). Mutations in the Prf1 gene have been identified
in patients with familial HLH (FHL) type 2 (Stepp et al.,
1999; Goransdotter Ericson et al., 2001). These patients
exhibit impaired NK cell and CTL cytotoxicity but mark-
edly elevated amounts of Th1 and Th2 cytokines, sug-
gestive of dysregulated immune responses (Henter
et al., 1991; Ohga et al., 1993; Egeler et al., 1996;
Schneider et al., 2002). Interestingly, disease onset in
FHL patients has been linked to bacterial and viral infec-
tions (Imashuku et al., 1994; Hoang et al., 1998). Addi-
tional evidence for the role of Prf1 in immunoregulation
has emerged in mouse models of autoimmune disease
(Malipiero et al., 1997; Peng et al., 1998). By contrast,
virtually nothing is known about the role of the Gzms in
immunoregulation.
MCMV-infectedPrf12/2mice exhibit increased viral ti-
tres (Tay and Welsh, 1997; Loh et al., 2005) and mortality
(Loh et al., 2005). Increased viral titres have also been
reported in Gzma2/2Gzmb2/2 mice, but only in salivary
glands (Riera et al., 2000). Here, we compared the role of
Prf1 and Gzms during MCMV infection, with the inten-
tion of specifically defining the relevance of these major
components of the cytotoxic granule pathway in viral
clearance and immunopathology. Our studies demon-
strated that Prf1 and Gzms play distinct roles in defen-
sive immunity and immunopathology, with only Prf12/2
hosts developing a HLH-like syndrome characterized
by overt organ damage resulting from the dysregulated
production of TNF-a and IFN-g.
Results
The Role of Prf1 and Gzma and/or Gzmb
in Controlling MCMV Replication In Vivo
To determine the role of Gzma, Gzmb, and Prf1 in the
control of MCMV infection, virus replication was as-
sessed in mice deficient in Prf1 (B6.Prf12/2) and in mice
deficient in Gzma and Gzmb (B6.Gzma2/2Gzmb2/2).
Like the 129SvJ.Gzmb2/2 (Pham et al., 1996) from which
they were derived, B6.Gzma2/2Gzmb2/2 mice are also
expected to lack Gzm c, d, f, and g (Waterhouse et al.,
2006). The replication of MCMV was assessed in the prin-
cipal target organs (spleen, liver, lungs, and salivary
glands) of Gzma2/2Gzmb2/2, Prf12/2, and WT mice
over an 18-day period to assess the relevance of these
effector molecules during the early and persistent phaseof MCMV infection (Figure 1). Prf1 was critical for the
control of MCMV replication, and mice lacking this mol-
ecule showed significantly elevated viral titres in the
spleen, liver, and lungs (Figure 1) and died at days 7–9
after infection.Gzma2/2Gzmb2/2mice also exhibited in-
creased sensitivity to MCMV infection, with significantly
elevated titres in the spleen, liver, and lungs (Figure 1). In
these mice, MCMV titres reached peak levels at day 6
after infection in the visceral organs, but then started to
decrease (Figure 1). Viral titres in the salivary glands
were also increased in Gzma2/2Gzmb2/2 mice at day
10 after infection (Figure 1).
Given the important role of Gzma and Gzmb in the
control of MCMV replication, we investigated the indi-
vidual roles of these molecules by assessing MCMV rep-
lication in Gzma2/2 and Gzmb2/2 mice. Gzmb2/2 mice
lack Gzm b, c, d, f, and g (Pham et al., 1996). Viral titres
in the spleen and lungs of mice deficient only in Gzma or
Gzmb were essentially equivalent to those observed in
WT mice (see Figure S1 in the Supplemental Data avail-
able online), suggesting that, at least during the acute
phase of infection, Gzma and Gzmb are able to compen-
sate for each other in relation to the activities required
for viral control in these organs. In contrast, in the liver,
both Gzma2/2 and Gzmb2/2 mice showed significantly
elevated viral titres at days 2 and 4 after infection, with
Gzmb2/2 mice showing the greatest increases (Fig-
ure S1). Together, these data indicate that Prf1 and
Gzma Gzmb are important in controlling replicating
virus, but only Prf1 is critical to host survival. Thus, in ad-
dition to an essential role in antiviral activities, Prf1 con-
tributes to other aspects of viral immunopathology in
this model.
Prf12/2 Mice Exhibit Greater MCMV Pathology
than Do Gzma2/2Gzmb2/2 Mice
Given the mortality observed in MCMV-infected Prf12/2
mice, we next assessed the extent of spleen and liver
damage at day 7–8 after infection in Prf12/2 and
Gzma2/2Gzmb2/2mice (Figure 2). Although the number
of foci of MCMV infection were comparable in the livers
of Prf12/2 and Gzma2/2Gzmb2/2 (Prf12/2: 45 6 3;
Gzma2/2Gzmb2/2: 38 6 2 foci) (Figures 2A and 2B),
the livers ofPrf12/2mice (Figure 2A) exhibited increased
areas of disseminated necrotic hemorrhage, compared
to those of Gzma2/2Gzmb2/2 mice (Figure 2B). Minimal
or no damage was observed in the livers of WT mice at
day 7–8 after MCMV infection, although a few foci of in-
fection could still be detected (Figure 2C). The spleens
of MCMV-infected Prf12/2 mice (Figure 2D) showed
a greater degree of damage than did the spleens of
Gzma2/2Gzmb2/2 mice (Figure 2E), as demonstrated
by extensive loss of organ architecture and severe non-
focal hemorrhage. Minimal or no damage was observed
in the spleens of WT mice (Figure 2F). The extensive
hepatocellular damage observed in Prf12/2 mice was
corroborated by liver function analyses, which showed
increased amounts of alanine transaminase (ALT) and
aspartate aminotransferase (AST) in the sera of Prf12/2
compared to Gzma2/2Gzmb2/2 and WT mice (data
not shown). Overt pathology was also observed in the
lungs of Prf12/2 mice, characterized by widespread
pulmonary hemorrhage and air-space remodelling
(data not shown). Together, these data showed that
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837Figure 1. Increased MCMV Replication in
Mice Lacking Prf1 or Gzms
Mice were infected with MCMV (13 104 PFU).
Titres are presented as the mean6 SEM. Sta-
tistical analysis utilized a Mann-Whitney test
after combining the results from three inde-
pendent experiments, each using at least
three mice per group. *p < 0.05; **p < 0.01;
***p < 0.001. Cross indicates mice suc-
cumbed to MCMV infection at this time.
BLD, below detection limit. Diamond or black
bar, B6 WT; circle or gray bar,Prf12/2; square
or white bar, Gzma2/2Gzmb2/2.in the absence of Prf1, MCMV infection leads to
overt immunopathology characterized by widespread
hemorrhage.
MCMV Infection Results in Dysregulated Cytokine
Production in the Absence of Prf1
IFN-g and TNF-a are important antiviral cytokines (Or-
ange and Biron, 1996), but their dysregulated produc-
tion can be detrimental. In MCMV infection, TNF-a con-
tributes to liver pathology and is responsible for hepatic
necrosis (Orange et al., 1997). Similarly, mice infected
with lethal doses of MCMV develop a shock-like syn-
drome characterized by high levels of TNF-a and IFN-g
(Trgovcich et al., 2000). Here we measured the amounts
of IFN-g and TNF-a in the sera of MCMV-infectedPrf12/2,
Gzma2/2Gzmb2/2, and WT mice. IFN-g concentrations
were increased in serum samples from infected Prf12/2,
Gzma2/2Gzmb2/2, and WT mice at day 2 after infection
but subsided to marginally detectable amounts by day
4 after infection (Figure 3). A second burst of IFN-g
was observed at day 6 after infection in both Prf12/2
and Gzma2/2Gzmb2/2; in contrast, IFN-g concentra-
tions remained low in WT mice at day 6 after infection
(Figure 3). Increases in the serum concentration of
TNF-a were observed in infected Prf12/2 compared to
Gzma2/2Gzmb2/2 and WT mice at both days 2 and 6 af-
ter infection (Figure 3). Although significantly increased
TNF-a concentrations were observed in Gzma2/2Gzmb2/2
compared to WT mice, the amounts of TNF-a at day 6
after infection were highest in Prf12/2 (Figure 3). Thus,
in the late stage of acute MCMV infection, Prf12/2
mice showed the most elevated concentrations ofTNF-a and IFN-g, suggesting that the dysregulated
production of these cytokines, and principally TNF-a,
may contribute to the immunopathology and mortality
observed in Prf12/2 mice.
Cellular Source of IFN-g and TNF-a in the Late Stage
of Acute MCMV Infection
Having observed a marked increase in the serum con-
centration of IFN-g and TNF-a in Prf12/2 mice, we set
out to define the cellular source of these cytokines by
using intracellular cytokine staining (ICS) analysis. The
frequencies of immune cell subsets (Figure S2) and the
frequencies of cells in various subsets that were produc-
ing IFN-g or TNF-a were measured in Prf12/2, Gzma2/2
Gzmb2/2, and WT mice at days 2, 4, and 6 after MCMV
infection. Unfortunately, when mice were infected with
a high dose of virus, i.e.,R53 103 plaque-forming units
(PFU), overt cell death prevented reproducible ICS anal-
ysis. Thus, for ICS analysis, a lower viral dose (1 3 103
PFU) was used. Although the serum concentrations of
cytokines measured after low dose infection were lower,
they followed the same trend observed after infection
with high viral doses (data not shown). It is worth noting
that cytokine production was measured directly ex vivo
without further restimulation. At day 2 after infection,
when both IFN-g and TNF-a could be detected in sera
of infected mice by ELISA (Figure 3), the principle
cellular source of these cytokines was the same in WT,
Prf12/2, and Gzma2/2Gzmb2/2 mice. IFN-g was pro-
duced principally by NK1.1+TCRb2 NK cells, whereas
TNF-a was produced principally by CD11b+F4/80+ cells
(data not shown).
Immunity
838Figure 2. MCMV Infection Causes More Damage in Prf12/2 Mice than in Gzma2/2Gzmb2/2 Mice
Prf12/2 mice (A and D), Gzma2/2Gzmb2/2 mice (B and E), and B6 WT mice (C and F) were infected with 1 3 104 PFU MCMV, and spleens and
livers were collected on day 7 or 8 for analysis. Livers from (A) Prf12/2, (B) Gzma2/2Gzmb2/2, and (C) B6 WT mice. Areas of diffuse, nonfocal
hemorrhage (red arrow) and necrosis (black arrow) and viral foci of inflammation (blue arrows) are marked. (A1)–(A3) show higher magnification
(320) of regions from (A) chosen to exemplify the specific histopathology defined by the arrows. Spleens from (D) Prf12/2, (E) Gzma2/2Gzmb2/2,
and (F) B6 WT mice. (A)–(C),310; (D)–(F),34; (A1)–(A3),320. The results are representative of three independent experiments, each with at least
four mice per group.At day 6 after infection, analysis of spleen and liver
lymphocytes showed that NK1.1+TCRb2 cells and
CD8+TCRb+ cells were the main producers of IFN-g
(Figure 4), whereas TNF-a was produced mainly by
CD11b+F4/80+ cells and CD4+TCRb+ cells (Figure 5).
In Prf12/2 mice, the frequencies of IFN-g+ cells in
the NK1.1+TCRb2, CD8+TCRb+, CD11b+F4/80+, and
CD4+TCRb+ compartments were higher compared to
both Gzma2/2Gzmb2/2 and WT mice (Figure 4) withone exception. In the liver, the frequencies of IFN-g+
CD11b+F4/80+ cells were similarly increased in both
Prf12/2 and Gzma2/2Gzmb2/2 mice compared with
WT mice (Figure 4H). The frequencies of TNF-a+ cells in
the CD11b+F4/80+, CD4+TCRb+, NK1.1+TCRb2, and
CD8+TCRb+ compartments were highest in Prf12/2
mice (Figure 5). Most of the TNF-a in Prf12/2 mice was
produced by CD11b+F4/80+ cells in the spleen. Cells in
the CD11b+F4/80+ gate that produce TNF-a include theFigure 3. IFN-g and TNF-a Concentrations
Are Raised in MCMV-Infected Prf12/2 Mice
Mice were infected with 5 3 103 PFU MCMV,
and serum concentrations of IFN-g and TNF-a
were measured. Mean 6 SEM from data
pooled from 2–5 independent experiments,
each with three mice per group, are shown.
Day 6 data represent mean 6 SEM from five
independent experiments with a total of at
least 10 mice per group. White bars, Prf12/2;
dashed gray bars, Gzma2/2Gzmb2/2; black
bars, B6 WT. Statistical analysis utilized a
Mann-Whitney test. *p = 0.0221; ***p <
0.0001 compared to B6 WT.
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and CD11b+F4/80+CD1152CD11c+/dim (w80%), as well
as CD11b+F4/80+CD1152CD11c+/dimTcRb+ (w20%).
The latter may represent activated CD4 T cells. Alto-
gether these results indicate that CD11b+F4/80+ mono-
nuclear cells (including macrophages and DCs) are the
main subset contributing to the elevated concentrations
of TNF-a observed late after MCMV infection in Prf12/2
mice, whereas NK1.1+TCRb2 and CD8+TCRb+ cells con-
tribute to the late production of IFN-g in these mice.
The Role of IFN-g and TNF-a in Organ Damage
in Prf12/2 Mice after MCMV Infection
To confirm the role of dysregulated cytokine production
in the immunopathology that leads to the demise of
Prf12/2 mice infected with MCMV, we analyzed organ
damage in Prf12/2 mice after neutralization of TNF-a or
IFN-g. MCMV-infected Prf12/2 mice were treated with
TNF-a or IFN-g antibodies, or an isotype control, at day
4 after infection, and the spleens and livers were ana-
lyzed by histopathology. We chose to block these cyto-
kines at day 4 after infection to avoid eliminating the di-
rect antiviral effects that they may play early in infection.
The numbers of inflammatory foci present in the livers
of Prf12/2 mice and Prf12/2 mice treated with anti-TNF-
a were similar (45 6 3 infected untreated versus 42 6 1
infected, anti-TNF-a treated). However, treatment with
anti-TNF-a markedly reduced liver damage, as shown
by a decrease in disseminated, nonfocal hemorrhage in
treated Prf12/2 mice (Figures 6A and 6D). In agreement
with our previous results, the amounts of systemic ALT
were markedly increased (>2000 IU/ml) at day 8 after
infection in Prf12/2 mice compared with WT (<50 IU/ml)
and Gzma2/2Gzmb2/2 (<100 IU/ml) mice. In contrast,
anti-TNF-a-treated Prf12/2 mice had decreased levels
of ALT (<1000 IU/ml), consistent with the reduced liver
damage observed in this group of mice. Neutralization
of TNF-a did not affect viral titres (data not shown) or or-
gan pathology in WT orGzma2/2Gzmb2/2mice (Figures
6B, 6E, 6C, and 6F). However, the livers of MCMV-in-
fected Prf12/2 mice treated with anti-TNF-a displayed
a different histopathology from those of WT mice (Fig-
ures 6D and 6F), consistent with the finding that viral ti-
tres are still higher at day 6 after infection in these mice
(w104.5 PFU) compared to WT mice (w103 PFU). The
increased viral replication occurring in Prf12/2 mice is
reflected by the increased numbers of foci of infection
observed in the organs of these mice compared with
WT (Figures 6D and 6F). Importantly, the overt nonfocal
hemorrhage observed in Prf12/2 mice was resolved by
neutralizing TNF-a (Figures 6A and 6D).
Prf12/2 mice treated with anti-IFN-g showed a slight
decrease in liver damage compared to the untreated
Prf12/2 mice (data not shown). Neutralization of IFN-g
did not affect organ pathology in WT or Gzma2/2
Gzmb2/2 mice but increased the number of viral foci in
both groups of mice (data not shown), consistent with
an antiviral role of this cytokine at this site (Tay and
Welsh, 1997; Loh et al., 2005). Together, these results
indicate that TNF-a is the main contributor to the immu-
nopathology observed in Prf12/2 mice after MCMV in-
fection. A role for IFN-g cannot be completely excluded,
but it is difficult to determine given the important antiviral
effects of this cytokine in the liver.NK Cell Perforin Suppresses MCMV
Immunopathology
To independently determine the role of Prf1 in the immu-
nopathology observed in Prf12/2 mice infected with
MCMV, we compared the phenotype of MCMV-infected
Prf12/2 mice to that of Gzma2/2Gzmb2/2 and WT mice
depleted of NK cells prior to infection. NK cells are the
principal source of Prf1 during the acute phase of
MCMV infection in B6 mice. Like Prf12/2 mice, NK cell-
depleted Gzma2/2Gzmb2/2 succumbed to MCMV in-
fection by day 8 after infection (data not shown).
The frequencies of IFN-g- and TNF-a-producing cells
in Prf12/2, Gzma2/2Gzmb2/2, NK-depleted Gzma2/2
Gzmb2/2, and WT mice were measured in the spleen
at day 6 after MCMV infection. The total frequency of
both IFN-g- (Figure 7A) and TNF-a (Figure 7B)-produc-
ing cells was increased in Gzma2/2Gzmb2/2 mice after
depletion of NK cells, albeit to amounts lower than those
observed in infected Prf12/2 mice (Figures 7A and 7B).
Activated T cells (TCRb+ CD11b+/2) were found to be
the principal source of IFN-g (Figure 7A). In keeping
with results presented earlier, CD11b+ cells (other than
activated T cells, i.e., TCRb negative) were found to rep-
resent the main source of TNF-a in NK cell-depleted
Gzma2/2Gzmb2/2 mice (Figure 7B).
The less-than-expected increase in IFN-g-producing
cells in NK-depleted Gzma2/2Gzmb2/2 mice is consis-
tent with our earlier observation that the principal source
of IFN-g at day 6 after infection are NK1.1+TCRb2 NK
cells (Figures 4C and 4G). Similarly, a less-than-ex-
pected increase in TNF-a+ cells was seen in NK-depleted
Gzma2/2Gzmb2/2 mice. An analysis of NK1.1 expres-
sion on the CD11b+F4/80+ cells that represent the main
source of TNF-a revealed thatw20% of the cells in this
compartment are in fact NK1.1+ and are therefore likely
to have been eliminated by our depletion regime. Impor-
tantly, however, our mortality studies, showing that, like
Prf12/2 mice, Gzma2/2Gzmb2/2 mice depleted of NK
cells succumb to MCMV infection (data not shown),
suggested that NK cell-derived Prf1 participates in im-
munopathology. Histological analysis was therefore un-
dertaken to compare the extent of damage induced by
MCMV infection in NK-depleted Gzma2/2Gzmb2/2
mice. The nature and degree of spleen, lung (data not
shown), and liver damage observed in Prf12/2 mice
(Figure 7C) was equivalent to that observed in NK cell-
depleted Gzma2/2Gzmb2/2 mice (Figure 7E). Although
the number of foci of MCMV infection were comparable
in the livers of NK cell-sufficient (Figure 7D) and NK
cell-depleted (Figure 7E) Gzma2/2Gzmb2/2 mice, the
livers of the latter exhibited increased areas of severe
disseminated nonfocal hemorrhage and necrosis similar
to those observed in MCMV-infected Prf12/2 mice
(Figure 7C). Overt immunopathology, characterized by
widespread pulmonary hemorrhage and air-space re-
modelling, was also observed in the lungs of both
Prf12/2 mice and NK cell-depleted Gzma2/2Gzmb2/2
mice, but not in Gzma2/2Gzmb2/2 mice with an intact
NK cell compartment (data not shown). As noted above,
both Prf12/2 mice and NK cell-depleted Gzma2/2
Gzmb2/2 mice died shortly after MCMV infection (day
7–8 after infection) (data not shown). These results sup-
port the independent role of Gzms in limiting viral infec-
tion and the role of Prf1 in limiting immunopathology.
Immunity
840Figure 4. The Source of IFN-g in MCMV-Infected Prf12/2 or Gzma2/2Gzmb2/2 Mice
Mice were infected with 1 3 103 PFU MCMV. Expression of IFN-g in (A) CD8+TCRb+, (B) CD4+TCRb+, (C) NK1.1+TCRb2, and (D) CD11b+F4/80+
splenocytes is shown. Expression of IFN-g in liver lymphocyte subsets is as follows: (E) CD8+TCRb+, (F) CD4+TCRb+, (G) NK1.1+TCRb2, (H)
CD11b+ F4/80+. Values refer to the percentage of cells within each subset that are positive for IFN-g. The percentage of IFN-g+ cells was
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source of Prf1 in our model of viral infection and
show that NK cell Prf1 is required for the elimination
of the TNF-a-producing CD11b+F4/80+ cells involved
in immunopathology.
Discussion
The studies described here elucidate the relative impor-
tance of Prf1 and the Gzms in the immune responses eli-
cited during viral infection. Our pathogenesis studies in
Prf12/2 and Gzma2/2Gzmb2/2 mice confirmed the es-
sential role of Prf1 in controlling MCMV replication (Tay
and Welsh, 1997; Loh et al., 2005) and demonstrated
a critical role for the Gzms in antiviral immunity during
early acute infection. Importantly, the current analyses
provide new and unequivocal evidence that Prf1 and
the Gzms play distinct roles in immunity and immunopa-
thology.
The role of Prf1 in the granule exocytosis pathway re-
quired for the cytolytic activity of both NK cells and T
cells is well established. In B6 mice, NK cells are the
principal effectors during the early acute phase of
MCMV infection, and the loss of Prf1 function, as ex-
pected, led to impaired virus control and increased
MCMV titres in the spleen, liver, and lungs. Similar in-
creases in viral titres were observed in the visceral or-
gans of Gzma2/2Gzmb2/2 mice, suggesting that, like
Prf1, these molecules are required to limit viral replica-
tion. Interestingly, the antiviral roles of the Gzms seem
to be largely redundant, and deficiency in either Gzma
only or Gzmb cluster only did not markedly affect viral
titres. Despite the elevated viral titres observed early in
infection, Gzma2/2Gzmb2/2 mice, unlike Prf12/2 mice,
were able to control the virus and, importantly, survived
the infection. Thus, Prf1 is required not only for the con-
trol of MCMV replication, but also to limit the pathology
that accompanies infection. Although our data indicate
that Gzma and the b cluster Gzms do not play a role in
immunopathology, the relevance of other members of
the Gzm family and of nongranzyme granule proteins re-
quires further investigation. It is possible, and indeed
likely, that Prf1 exerts some of its killing effects in asso-
ciation with granule proteins other than Gzma and the
b cluster Gzms. Gzm c, k, and m have been shown to in-
duce cell death when delivered with Prf1 in vitro (Mac-
Donald et al., 1999; Johnson et al., 2003; Kelly et al.,
2004) and thus are possible candidates in mediating
the Prf1-dependent killing that occurs in the absence
of Gzma and b. The recent suggestion that Gzmc may
not be lost in Gzmb cluster-deficient mice (Waterhouse
et al., 2006) justifies further investigation of the possible
relevance of this Gzm.
To better define what role Prf1 may play in limiting the
pathology that occurs after viral infection, we closely
analyzed the defects that develop in Prf1-deficient
mice after MCMV infection and before these mice die.
Histological examination revealed overt organ disrup-
tion in the spleen, liver, and lungs. The pathology
observed in MCMV-infected Prf12/2 mice was charac-
terized principally by disseminated nonfocal hemor-rhage and necrosis. Importantly, these characteristics
were not observed in infected Gzma2/2Gzmb2/2 mice.
Concomitant with the increased immunopathology, the
frequencies of NK cells, CD8+ T cells, CD11b+ cells,
and CD11c+ cells were increased in Prf12/2 mice, con-
sistent with a role for Prf1 in eliminating activated
immune effectors, as well as infected cells. DCs
(CD11c+CD11b+F4/80+) and macrophages (CD11b+F4/
80+CD115+) are important targets of MCMV infection
and replication (Brautigam et al., 1979; Jahn et al.,
1999; Hanson et al., 1999; Andrews et al., 2001). In the
absence of Prf1, we observed an incremental accumula-
tion of both macrophages and DCs, consistent with the
inability to eliminate infected cells, together with an
accumulation of CD8+ T cells, compatible with impaired
deletion of activated effectors. In addition to being
targets of infection, DCs and macrophages play central
roles in antiviral immunity through their capacity to
produce proinflammatory cytokines with both direct
and indirect antiviral activities. Thus, an accumulation
of these cells could potentially result in dysregulated cy-
tokine production. Indeed, when we analyzed cytokine
concentrations in the sera of infected mice, we found
that MCMV infection of Prf12/2 mice was accompanied
by an increased secretion of both IFN-g and TNF-a. It is
worth noting that this occurred early (day 2) as well as
later (day 6) in infection. Despite the important direct
antiviral activities of these cytokines and their role in
modulating the initiation and amplification of both innate
and adaptive immune responses, they can also have
detrimental effects. A role for TNF-a in the etiology of
MCMV-induced hepatic damage has been described
(Orange et al., 1997). High concentrations of TNF-a
and IFN-g late during MCMV infection have also been
associated with the development of severe hepatitis in
lethally infected mice (Trgovcich et al., 2000). Impor-
tantly, the source of these cytokines and the molecular
events that precede their dysregulated production
have, until now, not been defined. In this report we
have clearly established that a lack of Prf1 function
leads to the increased production of both TNF-a and
IFN-g in the late stages of infection before the mice
die. Furthermore, we have established the cellular
source of these cytokines and have shown that
CD11b+F4/80+ mononuclear cells and CD4+ T cells are
the main producers of TNF-a late after MCMV infection
in Prf12/2 mice, whereas NK1.1+TCRb2 and CD8+
T cells contribute to the late production of IFN-g in these
mice. CD4+ T cells are a source of TNF-a, albeit not as
prominent as CD11b+F4/80+ mononuclear cells. Indeed,
w1.6 3 106 TNF-producing CD11b+F4/80+ cells are
present in the spleen of Prf12/2mice compared with
w0.7 3 106 in WT mice at day 6 after infection. In con-
trast, the number of TNF-a-producing CD4+ T cells is
higher in WT mice. Although CD4+ T cells may contrib-
ute pathogenic TNF-a, CD4 depletion, commenced at
the time of infection, did not ameliorate the pathology
seen in Prf12/2 mice (data not shown). Importantly,
our depletion studies have shown that NK cells are the
principal source of Prf1 in our model and have con-
firmed that NK cell-derived Prf1 is required to eliminatedetermined via the gates shown, which were set with an isotype control. Values represent those from the individual mouse shown. Plots are rep-
resentative of two independent experiments, each with three mice per group.
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842Figure 5. The Source of TNF-a in MCMV-Infected Prf12/2 or Gzma2/2Gzmb2/2 Mice
Mice were infected with 13 103 PFU of MCMV. Expression of TNF-a in (A) CD8+TCRb+, (B) CD4+TCRb+, (C) NK1.1+TCRb2, and (D) CD11b+F4/80+
splenocytes is shown. Expression of TNF-a in specific liver lymphocyte subsets is as follows: (E) CD8+TCRb+, (F) CD4+TCRb+, (G) NK1.1+TCRb2,
(H) CD11b+ F4/80+. Values refer to the percentage of cells within each subset that are positive for TNF-a. The percentage of TNF-a+ cells was
determined via the gates shown, which were set with an isotype control. Plots are representative of two independent experiments, each with
three mice per group.
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843Figure 6. Blocking TNF-a Ameliorates Organ Damage in MCMV-Infected Prf12/2 Mice
Mice were infected with 1 3 104 PFU MCMV and, on day 4 after infection, treated with anti-TNF-a (D–F) or isotype control (A–C). Livers were
harvested for analysis on day 7 or 8 after infection. Livers from MCMV-infected (A)Prf12/2, (B)Gzma2/2Gzmb2/2, and (C) B6 WT mice are shown.
Livers from anti-TNF-a-treated MCMV-infected (D) Prf12/2, (E)Gzma2/2Gzmb2/2, and (F) B6 WT mice are also shown. Areas of diffuse, nonfocal
hemorrhage (red arrow) and necrosis (black arrow) are marked. The results are representative of three independent experiments, each with at
least four mice per group. Magnification, 310.the TNF-a-producing CD11b+F4/80+ cells involved in
immunopathology.
The histological and immunological phenotype that
characterizes MCMV-infected Prf12/2mice resembles
that observed in HLH patients. Characteristically, the
majority of individuals presenting with this disease carry
mutations in both their Prf1 alleles (Stepp et al., 1999;
Feldmann et al., 2002). Clinically, HLH patients present
with disease after a viral infection, and it is thought
that the underlying cause is the inability to control the
activation and expansion of immune effectors (Cline,
1994; Watson et al., 1994), resulting in an overproduc-
tion of proinflammatory cytokines, including TNF-a
and IFN-g, which contribute to pathogenesis of the
disease (Henter et al., 1991; Ohga et al., 1993). In mouse
models, Prf1 deficiency has also been linked to immuno-
pathology after viral infections. For example, mice in-
fected with LCMV show increases of both virus-specific
T cells and antigen-presenting cells, concomitant with
increases in TNF-a and IFN-g (Walsh et al., 1994; Binder
et al., 1998; Matloubian et al., 1999; Kagi et al., 1999; Jor-
dan et al., 2004). In our model, we observed a similar
phenotype. Although the immunopathology that de-
velops in MCMV-infected Prf12/2 mice appears to in-
volve both TNF-a and IFN-g, neutralization studies
have identified TNF-a as the principal contributor. This
is unlike LCMV infection, where IFN-g appears to drive
the development of the HLH-like syndrome (Matloubian
et al., 1999; Jordan et al., 2004). Furthermore, in LCMV-
infected Prf12/2mice, increased viral burdens, resulting
in dysregulated antigen presentation to CD8+ T cells, are
thought to underpin the excessive production of IFN-g
(Jordan et al., 2004). In our model, viral burden does
not appear to play as major a role, since Gzma2/2Gzmb2/2 mice, which exhibited increases in viral titers
similar to those observed in Prf12/2 mice, did not de-
velop the pathology observed in mice lacking Prf1, nor
did they succumb to infection. We favor the hypothesis
that the damage that occurs in MCMV-infected Prf12/2
mice results from dysregulated cytokine production re-
sulting from the inability to eliminate not only infected
targets, but also, and perhaps most importantly, acti-
vated immune effectors.
Because TNF-a and IFN-g can be synergistic in their
activities, it is possible that blocking both of these cyto-
kines may more effectively prevent the pathology ob-
served in MCMV-infected Prf1-deficient mice. Several
studies (Tay and Welsh, 1997; Loh et al., 2005), including
our own (data not shown), have clearly shown the impor-
tance of IFN-g-mediated activities in controlling MCMV
replication, especially in the liver. Thus, the synergistic
activities of TNF-a and IFN-g in the context of liver
immunopathology are likely to be confounded by the
antiviral effects of IFN-g. Further studies to address
this issue will need to temporally neutralize IFN-g during
late-stage infection.
In relation to the disease that developed in mice lack-
ing Prf1 after MCMV infection and its similarity to an
HLH-like syndrome, it is worth noting that MCMV infec-
tion in mice closely resembles HCMV infection in hu-
mans and that HCMV is one of the viral pathogens
thought to trigger disease in HLH patients (Hoang
et al., 1998; Imashuku et al., 2005). Given the role of
TNF-a in the disease process observed in MCMV-in-
fected Prf12/2 mice, it is possible that transient treat-
ment with TNF inhibitors (e.g., infliximab or adalimumab,
anti-human TNF antibodies, or etanercept, a soluble p75
TNF receptor) at the time of initial disease presentation
Immunity
844Figure 7. Depletion of NK Cells from Gzma2/2Gzmb2/2 Mice Increases the Frequency of Cells Producing IFN-g and TNF-a and Causes Organ
Damage Similar to that Observed in Prf12/2 Mice
(A and B) Mice were infected with 53 103 PFU MCMV. A group of Gzma2/2Gzmb2/2 mice were depleted of NK cells. Splenocytes were isolated
on day 6 after infection from test mice and from uninfected control mice and cytokine production determined by ICS. Expression of CD11b and
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845might improve the prognosis of HLH patients whose dis-
ease is triggered by a viral infection. A similar therapeu-
tic protocol may also be useful for treating refractory
HLH patients. A recent report, describing the successful
treatment of a patient with refractory HLH with infliximab
(Henzan et al., 2006), provides support for the clinical
potential of such an approach.
The increased viral titres observed in the organs of
Gzma2/2Gzmb2/2 mice indicate that these Gzms play
an important role in the control of MCMV replication.
The consequences of the lack of these Gzms during
MCMV infection was previously analyzed (Riera et al.,
2000); these studies concluded that the phenotype in
Gzma2/2Grzb2/2 mice was weak and that these mole-
cules partly contributed to the elimination of virus from
the salivary glands (Riera et al., 2000). Based on the cur-
rent results, we conclude that Gzma and Gzmb are an
essential component of the machinery involved in con-
trolling MCMV replication in visceral organs during
acute infection. Insights in the possible roles of Gzms
in antiviral immunity are provided by analysis of these
molecules in another viral system. Gzma2/2Grzb2/2
mice cannot control ectromelia virus infection and die
after receiving >101 PFU (Mullbacher et al., 1999). It
has been proposed that the antiviral effects of Gzma
and Gzmb may be independent of their function as ef-
fector molecules in cytotoxic lymphocytes (Regner and
Mullbacher, 2004). Indeed, as observed by others (Mull-
bacher et al., 1999), we found that NK cells derived from
MCMV-infected Gzma2/2Grzb2/2 mice were still capa-
ble of killing sensitive targets in vitro (data not shown).
Together, the available data suggest that the antiviral
effects mediated by Gzma and Grzb may relate to their
ability to facilitate DNA damage or fragmentation, the
proteolytic cleavage of proteins, or some other unrecog-
nized function. DNA fragmentation, for example, might
affect the stability of the double-stranded DNA viral
genome of MCMV. The earlier finding that Gzmb, in the
absence of Prf1, can degrade vesicular stomatitis virus
RNA and thus reduce viral production (Hommel-Berrey
et al., 1997) provides independent supporting evidence
for the relevance of this type of activity. Similarly, it is
possible that Gzma and Gzmb are involved in the de-
struction of structural viral proteins. Although CTL and
NK cells are the main producers of Gzms, it is not known
whether other cell types can also produce these mole-
cules, especially after viral infection. Interestingly,
MCMV can be detected in both NK cells and T cells early
after infection, but infection is not productive (A. Khong
and M.A.D.-E., unpublished observation). It is possible
that viral replication in these cell types is restricted
through antiviral activities mediated by Gzma and
Gzmb; studies to address this issue are in progress in
our laboratory. The possibility that the Gzms restrict viral
replication in cells such as NK cells and T cells, which in
WT mice show signs of infection only early and tran-
siently, is consistent with the increased viral titres ob-
served in the visceral organs of Gzma2/2Grzb2/2 miceas early as day 2 after infection. Finally, it should be
noted that Gzma2/2Grzb2/2 mice also lack Gzms c, d,
f, and g (Pham et al., 1996), possibly implicating these
molecules in the control of MCMV replication. Our anal-
ysis of MCMV infection in Gzmm2/2 mice suggests
a role, albeit minor, for this molecule in controlling
MCMV replication (Pao et al., 2005). Thus, the possible
relevance of other members of the Gzm family in control-
ling viral infection is also worthy of further investigation.
In conclusion, the current studies provide important
and previously unrecognized insights into the functions
of Prf1 and Gzma and Gzmb and demonstrate that these
molecules play distinct roles in antiviral immunity. Al-
though it is accepted that Prf1 and Gzms work in synergy
to deliver cytotoxic effects, the current results provide
evidence that these effectors play distinct roles in antivi-
ral immune responses. Prf1-deficient mice infected with
MCMV develop a HLH-like syndrome caused by the dys-
regulated production of TNF-a and IFN-g from activated
monocytes, NK cells, and CD8+ T cells. In contrast,
Gzma and Gzmb do not appear to play as critical a role
in the control of activated immune effectors but are es-
sential to control viral replication. Thus, Gzms have
unique antiviral functions that are independent of the cy-
tolytic activities they induce in collaboration with Prf1.
Experimental Procedures
Mice
B6 mice were purchased from the Animal Resources Centre (Perth,
Australia) or from the Walter and Eliza Hall Institute of Medical
Research (Melbourne, Australia). B6 mice lacking Prf1 (Prf12/2),
Gzma (Gzma2/2), Gzmb cluster (Gzmb2/2) (Pham et al., 1996), and
both Gzma and Gzmb cluster (Gzma2/2Gzmb2/2) were bred at the
Peter MacCallum Cancer Centre. Gzma2/2Gzmb2/2mice were orig-
inally obtained from M. Simon (Max-Planck Institut fur Immunbiolo-
gie, Freiburg, Germany). The mice were generated by backcrossing
129.Gzmb cluster-deficient mice (Ebnet et al., 1995) for six genera-
tions to B6 mice. These mice were further backcrossed two genera-
tions to Gzma2/2 mice generated from B6 embryonic stem cells
(Heusel et al., 1994). Thus, the Gzma2/2Gzmb2/2 strain used in all
of the experiments presented here was backcrossed a total of eight
generations to B6. Female mice (8–24 weeks) were used. Experi-
ments were approved by the Animal Ethics and Experimentation
Committee of the University of Western Australia according to the
guidelines of the NHMRC Australia.
Cells
Primary mouse embryo fibroblasts were cultured in MEM (GIBCO-
BRL Grand Island) supplemented with 10% neonatal calf serum
(GIBCO-BRL) and antibiotics (penicillin, 100 mg/ml, CSL; gentamy-
cin, 40 mg/ml, Pharmacia and Upjohn, Sydney, Australia).
Measuring MCMV Titres In Vivo
For pathogenesis studies, mice were infected i.p. with 1 3 104 PFU
of salivary gland propagated MCMV-K181-Perth diluted in PBS/
0.5% FCS. At indicated times, mice were sacrificed and organs col-
lected. Organs were individually weighed, homogenized in cold
MEM/2% NCS, and centrifuged at 30003 g for 15 min at 4C. Super-
natants were stored at280C and viral titres quantified as described
(Andrews et al., 2001). Viral titres were expressed as the log mean6
SEM. Statistical analyses were performed via the nonparametric
Mann-Whitney test.TCRb in (A) IFN-g+ and (B) TNF-a+ compartments is shown. The percentage of cells within each gate or quadrant is shown. Values represent
those from the individual mouse shown. Plots are representative of three independent experiments, each with three mice per group.
(C–E) Mice were infected with 1 3 104 PFU MCMV and organs harvested on days 6 or 8 after infection for analysis. Livers from (C) Prf12/2, (D)
Gzma2/2Gzmb2/2, and (E) NK-depleted Gzma2/2Gzmb2/2 mice are shown. The results are representative of two independent experiments,
each with three mice per group.
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846Preparation of Tissue Sections for Histological Analysis
Mice were infected i.p. with 1 3 104 PFU MCMV and sacrificed at
designated times. Spleen, liver, and lungs were removed, fixed in
10% buffered formol saline, and paraffin embedded, and tissue sec-
tions were prepared, stained with haematoxylin, and counterstained
with eosin.
Isolation and Phenotypic Analysis of Lymphocytes
For FACS analyses, mice were infected i.p. with 5 3 103 PFU of
MCMV. Livers were perfused via the portal vein with PBS2% FCS
(FACS buffer). Spleens and livers were teased apart and cells
passed through stainless steel sieves. Liver cells were resuspended
in a 37.5% isotonic Percoll solution (Pharmacia, Uppsala, Sweden)
to separate lymphocytes from hepatocytes and centrifuged (690 3
g for 12 min), hepatocytes were removed, and lymphocytes were
washed thoroughly in FACS buffer. Erythrocytes were osmotically
lysed in NH4Cl and the cells washed twice in FACS buffer. Spleno-
cytes and liver lymphocytes were incubated on ice for 30 min in
FACS buffer containing 10% normal goat serum to block non-
specific reactivity and then stained with specific antibodies. 7-
amino-actinomycin-D (7AAD) (Sigma-Aldrich, Sydney, Australia)
(2.5 mg/ml) was added to the final wash to exclude dead cells from
the analysis. Antibodies used: APC-conjugated anti-CD4 (RM4-5;
Biolegend, San Diego, CA), APC-Cy7-conjugated anti-CD8a (53-
6.7; Biolegend), PE-conjugated anti-NK1.1 (PK136; Biolegend),
FITC-conjugated anti-TCR-b (H57-597; Biolegend), PE-Cy7-conju-
gated anti-CD11b (M1/70; Biolegend), PE-conjugated anti-CD11c
(N418; Biolegend), FITC-conjugated F4/80 (CI:A3-1; CALTAG Labo-
ratories, CA), APC-conjugated anti-IA/IE (M5/114.15.2; Biolegend),
PE-conjugated CD115 (604B5 2E11; Serotec). The fluorescence-
labeled preparations were analyzed on a FACSCanto (BD Biosci-
ences, San Jose, CA). Files of 5000 or more positive events were
collected and analyzed on FloJo software (Stanford University, CA).
Quantitation of IFN-g and TNF-a by ELISA
Serum cytokines were measured after infection with 5 3 103 PFU of
MCMV. IFN-g was measured by standard sandwich ELISA with
Pharmingen antibodies. Detection was achieved with poly-horse-
radish peroxidase (poly-HRP) conjugated to streptavidin (CBL,
Amsterdam, Netherlands) and K-Blue (Elisa Systems, Brisbane,
Australia). Serum TNF-a was quantitated with the ELISAMAX kit (Bi-
olegend). Absorbance was measured at 450 nm with an automated
ELISA reader (SpectraMAX 250; Molecular Devices, Sunnyvale, CA).
Limits of detection were: IFN-g = 0.8 ng/ml; TNF-a = 0.01 ng/ml.
Intracellular Staining for IFN-g and TNF-a
Mice were infected with 13 103 PFU of MCMV and splenocytes iso-
lated as described above. Intracellular staining was performed as
described (Badovinac and Harty, 2000). PE-conjugated anti-NK1.1
(PK136; Biolegend), PE-Cy7-conjugated anti-CD4 (RM4-5; Biole-
gend), APC-Cy7-conjugated anti-CD8a (53-6.7; Biolegend), FITC-
conjugated anti-TCR-b (H57-597; Biolegend), PE-Cy7-conjugated
anti-CD11b (M1/70; Biolegend), PE-conjugated anti-CD11c (N418;
Biolegend), F4/80 conjugated to either biotin (CI:A3-1; Serotec,
NC) or FITC (CI:A3-1; CALTAG Laboratories), streptavidin-APC-
Cy7 (Biolegend), APC-conjugated anti-IA/IE (M5/114.15.2; Bio-
legend), PE-conjugated CD115 (604B5 2E11; Serotec), and APC-
conjugated anti-IFN-g (XMG1.2; Biolegend) or APC-conjugated
anti-TNF-a (MP6-XT22; Biolegend), in addition to the appropriate
isotype controls, were used. Cells were first stained for cell-surface
markers, followed by a fixation and permeabilization step (20 min in
Cytofix/Cytoperm, BD Biosciences) at 4C. Cells were then resus-
pended in PBS/0.1% saponin (PERM wash), stained for IFN-g or
TNF-a, washed in PERM wash, and resuspended in FACS buffer
for analysis on a FACSCanto (BD Biosciences). Files of 1000 or
more positive events were collected and analyzed on FloJo software
(Stanford University, CA).
In Vivo Neutralization of TNF-a and IFN-g
Mice were inoculated i.p. on day 4 relative to MCMV infection with
anti-TNF-a (TN3-19.12) (Sheehan et al., 1989) (300 mg/mouse) or
anti-IFN-g (H-22) (Schreiber et al., 1985) (200 mg/mouse).NK Cell Depletion
Mice were inoculated with anti-NK1.1 (PK136) at 0.25 mg/mouse on
days22, 0, 2 relative to administration of the virus. The effectiveness
of depletion was confirmed by testing splenocytes in a cytotoxicity
assay against NK cell-sensitive YAC-1 targets.
Supplemental Data
Two Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/5/835/DC1/.
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